The Close Correlation Between Heparanase and COX-2 Expression in Lymphangiogenesis of Cervical Cancer

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2014 Nov 6

PMID 25370734

Citations 5

Authors

Chao Zeng

Lili Chen

Zheng Yang

Shijun Sun

Affiliations

Soon will be listed here.

Abstract

Recent observations indicate the vital role of heparanase in tumor lymphangiogenesis. Moreover, heparanase is involved in angiogenesis in esophageal cancer through induction of COX-2. However, it is unclear whether heparanase is also associated with COX-2 in lymphangiogenesis of cervical cancer. In this study, heparanase, COX-2 and VEGF-C expression were examined in 80 cervical cancer cases by immunohistochemical staining. We also studied the correlation of heparanase and COX-2 expression with lymphangiogenesis of cervical cancer quantified as lymphatic vessel density. Our results showed that expressions of heparanase and COX-2 were associated with lymphangiogenesis of cervical cancer. Furthermore, a significant correlation was found between the expression of heparanase and COX-2 (P < 0.0001). Heparanase is positively correlated with expressions of COX-2 and VEGF-C. These findings revealed that heparanase may play important function in lymphangiogenesis of cervical cancer via the regulation of COX-2 expression.

Citing Articles

Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications.

Li Y, Gao X, Huang Y, Zhu X, Chen Y, Xue L Front Oncol. 2023; 13:1114042.

PMID: 37234990 PMC: 10206119. DOI: 10.3389/fonc.2023.1114042.

Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis.

Nguyen T, Paone S, Chan E, Poon I, Baxter A, Thomas S Cells. 2022; 11(20).

PMID: 36291066 PMC: 9599978. DOI: 10.3390/cells11203198.

Heparanase and the hallmarks of cancer.

Jayatilleke K, Hulett M J Transl Med. 2020; 18(1):453.

PMID: 33256730 PMC: 7706218. DOI: 10.1186/s12967-020-02624-1.

Studies of postpartum mammary gland involution reveal novel pro-metastatic mechanisms.

Wallace T, Tarullo S, Crump L, Lyons T J Cancer Metastasis Treat. 2019; 5.

PMID: 30847405 PMC: 6400586. DOI: 10.20517/2394-4722.2019.01.

Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Downregulates the Expression of Protumor Factors Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in a GM-CSF Receptor-Independent Manner in Cervical Cancer Cells.

Jiang N, Tian Z, Tang J, Ou R, Xu Y Mediators Inflamm. 2015; 2015:601604.

PMID: 26257474 PMC: 4518190. DOI: 10.1155/2015/601604.

References

Beckhove P, Helmke B, Ziouta Y, Bucur M, Dorner W, Mogler C . Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis. Clin Cancer Res. 2005; 11(8):2899-906. DOI: 10.1158/1078-0432.CCR-04-0664. View

Wang X, Wen W, Wu H, Chen Y, Ren G, Guo W . Heparanase expression correlates with poor survival in oral mucosal melanoma. Med Oncol. 2013; 30(3):633. DOI: 10.1007/s12032-013-0633-5. View

Dvir R, Vlodavsky I, Ilan N, Bitan M, Issacov J, Elhasid R . Heparanase expression in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2014; 61(10):1883-5. DOI: 10.1002/pbc.25046. View

Vlodavsky I, Goldshmidt O . Properties and function of heparanase in cancer metastasis and angiogenesis. Haemostasis. 2002; 31 Suppl 1:60-3. View

Huang G, Li B, Zhang M, Wei R, Yuan Y, Shi M . Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma. PLoS One. 2012; 7(8):e44061. PMC: 3432106. DOI: 10.1371/journal.pone.0044061. View

Bar-Sela G, Kaplan-Cohen V, Ilan N, Vlodavsky I, Ben-Izhak O . Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival. Histopathology. 2006; 49(2):188-93. DOI: 10.1111/j.1365-2559.2006.02469.x. View

Liu H, Yang Y, Xiao J, Lv Y, Liu Y, Yang H . COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer. Anat Rec (Hoboken). 2010; 293(11):1838-46. DOI: 10.1002/ar.21240. View

Zhang X, Huang D, Guo G, Chen G, Zhang H, Wan L . Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer. 2008; 8:4. PMC: 2253544. DOI: 10.1186/1471-2407-8-4. View

Cohen E, Doweck I, Naroditsky I, Ben-Izhak O, Kremer R, Best L . Heparanase is overexpressed in lung cancer and correlates inversely with patient survival. Cancer. 2008; 113(5):1004-11. PMC: 2625296. DOI: 10.1002/cncr.23680. View

10.

Elkin M, Ilan N, Friedmann Y, Papo O, PECKER I, Vlodavsky I . Heparanase as mediator of angiogenesis: mode of action. FASEB J. 2001; 15(9):1661-3. DOI: 10.1096/fj.00-0895fje. View

11.

Zhang Z, Chen Y, Zhao H, Xie C, Ding J, Hou Y . Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo. Cancer Biol Ther. 2007; 6(4):587-95. DOI: 10.4161/cbt.6.4.3888. View

12.

Miao H, Elkin M, Aingorn E, Stein C, Vlodavsky I . Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int J Cancer. 1999; 83(3):424-31. DOI: 10.1002/(sici)1097-0215(19991029)83:3<424::aid-ijc20>3.0.co;2-l. View

13.

Zhang Q, Ming J, Li Y, Zhang S, Li B, Qiu X . Heparanase expression correlates with angiogenesis and lymphangiogenesis in human lung cancer. Zhongguo Fei Ai Za Zhi. 2010; 12(8):864-7. DOI: 10.3779/j.issn.1009-3419.2009.08.06. View

14.

Di J, Zhou J, Zhou X, Gao X, Shao C, Pang J . Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer. Arch Med Res. 2009; 40(4):268-75. DOI: 10.1016/j.arcmed.2009.03.002. View

15.

Tang D, Piao Y, Zhao S, Mu X, Li S, Ma W . Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer. Med Oncol. 2014; 31(7):26. DOI: 10.1007/s12032-014-0026-4. View

16.

Xia F, Xu J, Zhang P, Zhang Y, Zhang Q, Chao Z . Glucose-regulated protein 78 and heparanase expression in oral squamous cell carcinoma: correlations and prognostic significance. World J Surg Oncol. 2014; 12:121. PMC: 4016628. DOI: 10.1186/1477-7819-12-121. View

17.

Jiao F, Bai S, Ma Y, Yan Z, Yue Z, Yu Y . DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancer. PLoS One. 2014; 9(3):e92190. PMC: 3954879. DOI: 10.1371/journal.pone.0092190. View

18.

Wang Q, Shen Y, Wang P, Li X . The expression of Heparanase mRNA and its clinical significance in Hepatocellular carcinoma. J Cancer Res Ther. 2013; 9(2):250-2. DOI: 10.4103/0973-1482.113377. View

19.

Parish C, Freeman C, Hulett M . Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta. 2001; 1471(3):M99-108. DOI: 10.1016/s0304-419x(01)00017-8. View

20.

Vlodavsky I, Friedmann Y . Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest. 2001; 108(3):341-7. PMC: 209369. DOI: 10.1172/JCI13662. View